Irritable Bowel Syndrome | Biopharma | Research & reports

Irritable Bowel Syndrome |... Irritable Bowel Syndrome | Epidemiology | Americas Data

October 2018

DRG Epidemiology's coverage of irritable bowel syndrome comprises...

DRG Epidemiology's coverage of irritable bowel syndrome comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of irritable bow......

Irritable Bowel Syndrome |... Irritable Bowel Syndrome | Epidemiology | Middle East & Africa Data

October 2018

DRG Epidemiology's coverage of irritable bowel syndrome comprises...

DRG Epidemiology's coverage of irritable bowel syndrome comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of irritable bow......

Irritable Bowel Syndrome |... Irritable Bowel Syndrome | Epidemiology | Asia Pacific Data

October 2018

DRG Epidemiology's coverage of irritable bowel syndrome comprises...

DRG Epidemiology's coverage of irritable bowel syndrome comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of irritable bow......

Irritable Bowel Syndrome |... Irritable Bowel Syndrome | Epidemiology | Mature Markets Data

October 2018

DRG Epidemiology's coverage of irritable bowel syndrome comprises...

DRG Epidemiology's coverage of irritable bowel syndrome comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of irritable bow......

Irritable Bowel Syndrome |... Irritable Bowel Syndrome | Epidemiology | Europe Data

October 2018

DRG Epidemiology's coverage of irritable bowel syndrome comprises...

DRG Epidemiology's coverage of irritable bowel syndrome comprises epidemiological estimates of key patient populations across forty-five countries worldwide. We report the prevalence of...

Irritable Bowel Syndrome |... Irritable Bowel Syndrome | Epidemiology | Emerging Markets Data

October 2018

DRG Epidemiology's coverage of irritable bowel syndrome comprises...

DRG Epidemiology's coverage of irritable bowel syndrome comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of irritable bow......

Irritable Bowel Syndrome | Unmet... Irritable Bowel Syndrome | Unmet Need | Detailed, Expanded Analysis (US/EU): Irritable Bowel Syndrome - Constipation Predominant

March 2018

MARKET OUTLOOK IBS-C is an indication ripe for emerging therapies; only...

MARKET OUTLOOK IBS-C is an indication ripe for emerging therapies; only three drugs have a label a......

Irritable Bowel Syndrome | Unmet... Irritable Bowel Syndrome | Unmet Need | Detailed, Expanded Analysis (US/EU): Irritable Bowel Syndrome-Diarrhea Predominant

December 2017

IBS-D is a highly prevalent disorder regularly encountered in general practice...

IBS-D is a highly prevalent disorder regularly encountered in general practice that is marked by excessive defecation and abdomi......

Research & Reports

Therapy Areas (8)

Autoimmune & Inflammation (8)

Gastrointestinal (8)

Irritable Bowel Syndrome (8)

Product / Solution (8)

Epidemiology (6)

Unmet Need (2)

Geography (5)

North America (2)

US (2)

Europe (1)

Asia Pacific (1)

Middle East / Africa (1)

8 Biopharma Reports

Irritable Bowel Syndrome |... Irritable Bowel Syndrome | Epidemiology | Americas Data

Irritable Bowel Syndrome |... Irritable Bowel Syndrome | Epidemiology | Middle East & Africa Data

Irritable Bowel Syndrome |... Irritable Bowel Syndrome | Epidemiology | Asia Pacific Data

Irritable Bowel Syndrome |... Irritable Bowel Syndrome | Epidemiology | Mature Markets Data

Irritable Bowel Syndrome |... Irritable Bowel Syndrome | Epidemiology | Europe Data

Irritable Bowel Syndrome |... Irritable Bowel Syndrome | Epidemiology | Emerging Markets Data

Irritable Bowel Syndrome | Unmet... Irritable Bowel Syndrome | Unmet Need | Detailed, Expanded Analysis (US/EU): Irritable Bowel Syndrome - Constipation Predominant

Irritable Bowel Syndrome | Unmet... Irritable Bowel Syndrome | Unmet Need | Detailed, Expanded Analysis (US/EU): Irritable Bowel Syndrome-Diarrhea Predominant

Company

Resources

Support

Social

Research & Reports

Category

Therapy Areas (8)

Autoimmune & Inflammation (8)

Gastrointestinal (8)

Irritable Bowel Syndrome (8)

Product / Solution (8)

Epidemiology (6)

Unmet Need (2)

Geography (5)

North America (2)

US (2)

Europe (1)

Asia Pacific (1)

Middle East / Africa (1)

8 Biopharma Reports

Company

Resources

Support

Social